XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 165.9 $ 147.1
Trade and other accounts receivable (less allowances of $9.6 million and $7.7 million respectively) 310.9 334.6
Inventories (less allowances of $27.2 million and $27.1 million respectively):    
Finished goods 248.3 259.3
Raw materials 108.4 113.8
Total inventories 356.7 373.1
Prepaid expenses 10.5 14.1
Prepaid income taxes 9.8 3.3
Other current assets 0.7 0.4
Total current assets 854.5 872.6
Net property, plant and equipment 242.3 220.9
Operating lease right-of-use assets 45.9 45.3
Goodwill 360.6 358.8
Net book amount at June 30 46.7 45.0
Deferred tax assets 5.9 5.9
Pension asset 49.1 48.1
Other non-current assets 5.8 7.1
Total assets 1,610.8 1,603.7
Current liabilities:    
Accounts payable 157.9 165.3
Accrued liabilities 174.7 202.9
Current portion of operating lease liabilities 14.3 13.9
Current portion of plant closure provisions 4.3 5.3
Current portion of accrued income taxes 13.7 18.4
Total current liabilities 364.9 405.8
Operating lease liabilities, net of current portion 31.6 31.4
Plant closure provisions, net of current portion 52.6 51.9
Accrued income taxes, net of current portion 11.6 21.0
Unrecognized tax benefits 14.0 13.4
Deferred tax liabilities 27.3 26.2
Pension liabilities and post-employment benefits 12.4 12.2
Other non-current liabilities 1.6 1.4
Total liabilities 516.0 563.3
Equity:    
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares 0.3 0.3
Additional paid-in capital 356.7 354.1
Treasury stock (4,688,514 and 4,788,966 shares at cost, respectively) (94.2) (95.4)
Retained earnings 969.1 924.2
Accumulated other comprehensive loss (139.7) (145.2)
Total Innospec stockholders' equity 1,092.2 1,038.0
Non-controlling interest 2.6 2.4
Total equity 1,094.8 1,040.4
Total liabilities and equity $ 1,610.8 $ 1,603.7